Connie Kasari is professor of human development and psychology at the University of California, Los Angeles. She is the principal investigator for several multi-site research programs and a founding member of the university’s Center for Autism Research and Treatment.
Connie Kasari
From this contributor
How much behavioral therapy does an autistic child need?
People tend to believe that, regardless of the treatment, more is always better. But is it?
How much behavioral therapy does an autistic child need?
Learning when to treat repetitive behaviors in autism
Some restricted and repetitive behaviors may have hidden benefits for people with autism, so scientists should work to find a happy medium between acceptance and change.
Learning when to treat repetitive behaviors in autism
School’s in
School-based interventions are arguably the best way to reach the truly underserved, under-represented and under-resourced children with autism, says Connie Kasari.
Explore more from The Transmitter
SHANK3 deficiency and behavior in mice; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 24 November.
SHANK3 deficiency and behavior in mice; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 24 November.
Remembering Mark Hallett, leader in transcranial magnetic stimulation
The long-time NINDS researcher, best known for studying movement disorders, has died at age 82.
Remembering Mark Hallett, leader in transcranial magnetic stimulation
The long-time NINDS researcher, best known for studying movement disorders, has died at age 82.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.